Login
Israel-Hamas Conflict
Airstrike
Parade
Benjamin Netanyahu
Military
World Cup
Donald Trump
Asian Politics
War
Social Media
Cricket
Soccer
Artificial Intelligence
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Clinical Trials Arena image

News from Clinical Trials Arena

If you want to know if Clinical Trials Arena is credible or reliable, look no further. We rank Clinical Trials Arena as Unknown factuality. Find out more about our methodology here.

Information about Clinical Trials Arena

Where is Clinical Trials Arena located?Clinical Trials Arena's Website

Media Bias Ratings

Do you diasgree?
Edit bias
Learn more about Media Bias Ratings.

Factuality

Learn more about  Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about  Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top Clinical Trials Arena News

FDA Approves Merck’s Enflonsia to Prevent RSV in Infants
Merck · United States

FDA Approves Merck’s Enflonsia to Prevent RSV in Infants

51% Center coverage: 37 sources
The Food and Drug Administration has approved a new drug from Merck designed to protect infants from respiratory syncytial virus, or RSV, a common but potentially serious seasonal illness.The drug, Enflonsia, is a long-acting monoclonal antibody intended to prevent RSV-related lower respiratory tract disease in newborns and infants entering their first RSV season.RSV is a leading cause of hospitalization among infants in the United States, espec…See the Story
Accelerated Biological Aging May Increase Risk of Dementia, Stroke
Dementia · Minnesota

Accelerated Biological Aging May Increase Risk of Dementia, Stroke

74% Center coverage: 15 sources
A hallmark of accelerated aging appears to be linked to an increased risk of dementia and stroke, a new study says.See the Story
Reeves Pumps Money Into NHS as Critics Warn Future Tax Rises ‘Almost Inevitable’
Rachel Reeves · London

Reeves Pumps Money Into NHS as Critics Warn Future Tax Rises ‘Almost Inevitable’

55% Left coverage: 11 sources
Chancellor Rachel Reeves set out how she would spend hundreds of billions of taxpayers’ money over the rest of the decade.See the Story

Novo Nordisk Moves Amycretin Into Phase 3 Trials For Weight Management, Becomes Europe's Largest Company - Novo Nordisk (NYSE:NVO)

57% Center coverage: 7 sources
Novo Nordisk A/S (NYSE:NVS) announced Thursday that it will advance subcutaneous and oral amycretin into phase 3 development in weight management. Amycretin is developed for subcutaneous and oral administration. The decision to advance subcutaneous and oral amycretin into phase 3 is based on feedback received from regulatory authorities following end-of-phase 2 interactions for subcutaneous and oral amycretin in weight management. Novo Nordisk p…Obesity · DenmarkSee the Story

UK Govt Injects Health Service with 'Record' Spending Boost

50% Center coverage: 6 sources
Britain's Labour government on Wednesday laid out its priorities for the coming years, injecting the ailing National Health Service with a "record" £29-billion ($39-billion) annual boost and pumping…Donald Trump · United KingdomSee the Story

Bavarian Nordic launches chikungunya vaccine trial for paediatric population

Bavarian Nordic has commenced a Phase III trial of its chikungunya vaccine, CHIKV VLP, targeting the paediatric population.The post Bavarian Nordic launches chikungunya vaccine trial for paediatric population appeared first on Clinical Trials Arena.Denmark · DenmarkRead Article

MSD begins Phase III trial of dengue vaccine

MSD has begun the randomised MOBILIZE-1 Phase III trial to assess the investigational quadrivalent vaccine, V181.The post MSD begins Phase III trial of dengue vaccine appeared first on Clinical Trials Arena.Vaccines · BrazilSee the Story

AI Could Personalise Clinical Trial Consent, but Privacy Concerns Remain

The technology’s potential to transform trials will need to be balanced with the challenge of instilling trust in participants.The post AI could personalise clinical trial consent, but privacy concerns remain appeared first on Clinical Trials Arena.Medical · MarylandSee the Story

Iptacopan (Fabhalta) Hits Primary Endpoint in Phase 3 APPULSE-PNH Trial

Novartis has announced the safety and efficacy of iptacopan, a twice-daily oral monotherapy for adult patients who switched from eculizumab or ravulizumab.HealthcareSee the Story

ImmuneWalk presents topline data from Phase I trial’s SAD part of IW-601

ImmuneWalk Therapeutics has presented positive topline data from the SAD part of the Phase I trial of IW-601.The post ImmuneWalk presents topline data from Phase I trial’s SAD part of IW-601 appeared first on Clinical Trials Arena.Read Article

Clinician capacity remains a major bottleneck in UK’s push for cancer trials

Experts say clinicians struggle for time to support clinical studies, limiting the scope of progress from regulatory revisions.The post Clinician capacity remains a major bottleneck in UK’s push for cancer trials appeared first on Clinical Trials Arena.United Kingdom · United KingdomRead Article

Breaking News Topics Related to Clinical Trials Arena

Health

Health

United States

United States

Medical

Medical

United Kingdom

United Kingdom

News
For You
SearchBlindspotLocal